The Secret to a Clinician's Success Begins with a Healthy Gut: Bridget Briggs, MD

In this clinical monologue, Dr. Bridget Briggs explains how targeted gut health interventions can dramatically improve outcomes for patients with malabsorption, post‑gallbladder resection, and those undergoing chemotherapy or immunomodulatory therapy. She describes the role of microvilli enzymes (dipeptidases and disaccharidases) in nutrient breakdown and emphasizes the importance of stool testing for pancreatic elastase to guide pancreatic enzyme replacement, which can resolve steatorrhea, diarrhea, and irritable bowel symptoms. For patients lacking synchronized bile acid release after gallbladder removal, she advocates bile acid supplementation to restore essential fatty acid absorption and prevent frequent, urgent bowel movements. She also highlights the need to replenish immunoglobulins—using colostrum or whey‑based products—for individuals on chemotherapy, methotrexate, or other immune‑modulating drugs, noting that the gut’s rapidly dividing cells are especially vulnerable. Clinical anecdotes, including a patient named Nolan and references to Crohn’s disease, ulcerative colitis, and rheumatoid arthritis cohorts, illustrate the real‑world impact of these interventions.









